What We're Reading, July 11, 2016: US lawmakers who signed letters opposing the Medicare Part B demonstration received bigger monetary support from Big Pharma; e-cigarettes could push adolescents toward smoking cigarettes; and Hillary Clinton says she supports lowering Medicare enrollment age.
Lawmakers who were vocal in their opposition to CMS’ Medicare Part B demonstration proposal received significantly more financial support from the pharmaceutical industry than those who were not. Public Citizen reports that US representatives received 82% greater contributions (a total of $7,236,806 for 310 representatives) for their 2016 campaigns from the pharmaceutical and health products industry if they had signed either 1 of 2 letters that opposed the project. The 124 who did not, received a combined $1,585,857.
The FDA’s recent decision to regulate e-cigarettes could not have come at a more appropriate time. A new study released today in the journal Pediatrics has found that e-cigarette users had a 6-times greater likelihood of initiating cigarette use compared with those who did not use e-cigarettes. Further, the association was much stronger in the adolescent population interviewed for the study. The authors conclude that some of the e-cigarette users are teens who would not have smokes regular cigarettes if not exposed to vapes.
Two weeks before the Democratic National Convention, Hillary Clinton indicated that she supports a “public option” in health insurance. According to The Washington Post, the Clinton campaign released a statement that said she would support allowing people 55 and older to buy into Medicare. The statement also affirmed her support for increased funding for primary-care services at community-based centers in rural parts of the nation. Bernie Sanders is expected to endorse Clinton this week.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More